Halozyme Therapeutics | Acreedores Comerciales



Trade Creditors Cambio Fecha
Acadia Pharmaceuticals USD 16.19M 2.89M 2024-12
Agios Pharmaceuticals USD 16.64M 500K 2024-12
Alnylam Pharmaceuticals USD 88.42M 17.61M 2024-12
Amarin USD 40.51M 13.88M 2024-09
Amgen USD 1.91B 239M 2024-12
Baxter International USD 968M 127M 2024-12
Cytokinetics USD 20.37M 8.79M 2024-12
DBV Technologies USD 22.5M 2.68M 2024-09
Eli Lilly USD 3.23B 342.1M 2024-12
Halozyme Therapeutics USD 10.25M 2.15M 2024-12
Indivior 50M 4M 2024-09
Intra Cellular Therapies USD 26.07M 15.74M 2024-12
Ionis Pharmaceuticals USD 42.96M 33.91M 2024-12
MannKind USD 6.79M 348K 2024-12
Pfizer USD 5.63B 319M 2024-12
United Therapeutics 6M 357.9M 2024-12



Halozyme Therapeutics Acreedores Comerciales - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.